Accuracy and Clinical Findings of Saliva Digestive Biomarkers in Laryngopharyngeal Reflux Disease
The Laryngoscope · 2026
DOI: 10.1002/lary.70062 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Jerome R Lechien und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, UMONS Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium. Hauptthemen laut MEDLINE: Saliva, Laryngopharyngeal Reflux. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Koning Boudewijnstichting.
Abstract (Originalsprache)
Objective
To evaluate the diagnostic performance of multiple digestive enzyme biomarkers in detecting and characterizing laryngopharyngeal reflux disease (LPRD).
Methods
Patients with LPRD at the 24‐h hypopharyngeal‐esophageal multichannel intraluminal impedance‐pH testing (HEMII‐pH) were consecutively recruited from January 2020 to May 2024 from two European hospitals. The control group consisted of adults without symptoms. Prospective clinical data collection included demographics, gastrointestinal endoscopy, HEMII‐pH, reflux symptom score (RSS), and reflux sign assessment (RSA) findings. At baseline, pepsin, elastase, cholesterol, bile acids, trypsin, pancreatic, and gastric lipase were measured in saliva samples of LPRD patients and asymptomatic individuals. Sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy (receiver operating characteristic (ROC) curve and area under the curve (AUC)) were evaluated.
Results
One hundred and twenty‐three patients and forty‐eight asymptomatic individuals were prospectively recruited. Patients exhibited significantly elevated salivary pH and elastase levels, but decreased cholesterol compared to controls. Salivary cholesterol demonstrated superior diagnostic performance (AUC = 0.989), with a 2.05 mg/dL threshold yielding excellent sensitivity (100%), specificity (94.3%), and predictive values. Elastase showed moderate‐to‐high diagnostic performance (AUC = 0.811, threshold > 49.2 μg/mL). Combined RSS > 13 and salivary pH demonstrated robust diagnostic accuracy (SE = 88.8%, SP = 97.1%). Cholesterol positively correlated with 3‐month RSS ( r = 0.538).
Conclusion
Salivary cholesterol, elastase, and the salivary pH emerge as promising diagnostic biomarkers for LPRD, demonstrating superior accuracy to other digestive enzymes and potential value in predicting treatment outcomes. Level of Evidence III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, UMONS Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium.
- Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, Paris Saclay University, Phonetics and Phonology Laboratory (UMR 7018 CNRS, Université Sorbonne Nouvelle/Paris 3), Paris, France.
- Department of Otolaryngology, Elsan Polyclinic de L'atlantique, Poitiers, France.
- Department of Otolaryngology-Head and Neck Surgery, CHU Saint-Pierre, Brussels, Belgium.
- Department of Gastroenterology, CHU Saint-Pierre, Brussels, Belgium.
- Department of Anatomy, UMONS Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium.
ORCID-Profile: Jerome R Lechien
Förderung
- Koning Boudewijnstichting
Zitieren
APA
Lechien, J. R., El Ayoubi, M., Muls, V., Hans, S., Saussez, S., & De Vos, N. (2026). Accuracy and Clinical Findings of Saliva Digestive Biomarkers in Laryngopharyngeal Reflux Disease. The Laryngoscope. https://doi.org/10.1002/lary.70062
Vancouver
Lechien JR, El Ayoubi M, Muls V, Hans S, Saussez S, De Vos N. Accuracy and Clinical Findings of Saliva Digestive Biomarkers in Laryngopharyngeal Reflux Disease. The Laryngoscope. 2026. doi:10.1002/lary.70062
BibTeX
@article{Lechien2026,
author = {Lechien, Jerome R and El Ayoubi, Mariam and Muls, Vinciane and Hans, Stéphane and Saussez, Sven and De Vos, Nathalie},
title = {Accuracy and Clinical Findings of Saliva Digestive Biomarkers in Laryngopharyngeal Reflux Disease},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70062}
}
EUVIMED